Machine learning

#Artificial intelligence (AI) #Drug discovery #Investment #Machine learning

Pharmacelera raises $6m to advance AI drug discovery  

Deep tech company Pharmacelera has raised $6 million in an investment round to help accelerate its expansion in the United States and grow its platform.   Pharmacelera uses its proprietary quantum mechanics and artificial intelligence (QaiM) algorithms to find novel and diverse molecular candidates across the chemical “exaSpace”.   The company says its algorithms can generate… Read More

#News

#AI #Biomarkers #Machine learning #SLAS2026

The science behind SLAS2026 

DDW Editor Reece Armstrong examines some of the science that has emerged in the last year that is driving the conversations at SLAS 2026. SLAS always provides a great opportunity to assess what topics are in the minds of scientists within the drug discovery… Read More

#Exclusive Content

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

2026: What will change in preclinical and clinical development?

How will preclinical discovery and clinical trials change in the coming year? And what role will regulators play? Diana Turner asks industry leaders for their predictions for 2026. A number of innovations are predicted to influence R&D in 2026, in both preclinical and clinical trials, including… Read More

#Exclusive Content #Trends & Analysis

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

Drug discovery and development in 2026

Which drug modalities will dominate the market, and which global regions will be most influential? Diana Turner asks industry leaders for their predictions for 2026. The opportunities and challenges facing biotech and biopharma in 2026 are concisely summarised by Dr Kevin Land, Executive Medical Director Biotherapies… Read More

#Exclusive Content #Trends & Analysis

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

2026: An AI tipping point for drug discovery

How big a role will AI play in the coming year? Diana Turner asks industry leaders for their predictions. As with all sectors, the role of artificial intelligence (AI) in drug discovery is expected to significantly increase in 2026 and beyond. Richard Young, CSO… Read More

#Exclusive Content #Trends & Analysis

Therapeutic antibodies
#Absci #AI #AI / data analytics / healthtech / informatics #Antibody-based therapeutics #Biologics #Generative AI #Machine learning

How the next generation of AI is reshaping antibody drug discovery

This is the latest episode of the free DDW Narrated Podcast. The episode covers two articles written for DDW Volume 25, Issue 2, Spring 2024. The first article is called ‘Machine learning: developing next generation antibody therapeutics’. Ben Holland, CTO and Co-Founder of Antiverse, discusses how artificial intelligence and… Read More

#Featured Podcasts #Podcasts

Human brain
#Artificial intelligence (AI) #Automation #Deep learning #Drug discovery #eBook #Machine learning

eBook: AI – Advancing drug discovery and development

Over the last few years artificial intelligence (AI) has emerged as a key trend and an important area for investment in drug discovery, whether in preclinical research workflows, clinical trial design or regulation. “AI is evolving faster than any other lab technology with new models and… Read More

#News

eBook: AI – Advancing drug discovery and development
#Artificial intelligence (AI) #Automation #Deep learning #Drug discovery #eBook #Machine learning

AI – Advancing drug discovery and development

Over the last few years artificial intelligence (AI) has emerged as a key trend and an important area for investment in drug discovery, whether in preclinical research workflows, clinical trial design or regulation.

#DDW eBooks #Intelligence

Drug discovery concept
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Guide #Machine learning

Read the Guide: How AI is transforming drug discovery

Artificial intelligence (AI) for drug discovery and development can appear somewhat elusive at times. We have fullyadvanced AI capabilities in several parallel sectors and industries, but experts are cautious to label AI a cure-all, one-shot solution. While technology-driven sectors like cyber security or engineering, for instance, showcase the effects of AI-driven solutions easily, the… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Guide #Machine learning

How AI is transforming drug discovery

‘How AI is transforming drug discovery’ is an exclusive Guide published by DDW that examines the challenges and opportunities this technology is presenting throughout the industry. Read More

#DDW eBooks #DDW Guides

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Transforming drug discovery with AI and digital labs: Last chance to register

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Evaluate billions of compounds in record time

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Drug discovery #Foundational model #Genomics #Large language model (LLM) #Machine learning #Merck #Open source

Merck shares foundation model with the research community

Merck is expanding access to TEDDY (Transformers for Enabling Drug DiscoverY), its foundation model for drug discovery, by adding it to HuggingFace, the premier platform for open-source machine learning and LLMs.  TEDDY was created in partnership with the Boston Consulting Group (BCG) AI Science Institute and is… Read More

#News

Digital technology concept
#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: AI and digital workflows reshape pharmaceutical R&D

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: How is AI revolutionising drug discovery?

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News